Management of Patient with Persistent Chest Pain and Elevated Biomarkers
Risk Assessment and Classification
- The European Society of Cardiology recommends that a patient with persistent chest pain despite morphine administration, significantly elevated troponin, and elevated BNP is classified as having NSTE-ACS with ongoing ischemia, placing them in a high-risk category requiring urgent intervention 1, 4
- The presence of persistent chest pain, significantly elevated troponin level, and elevated BNP suggests a high-risk category, with the European Heart Journal citing the importance of urgent intervention in such cases 1, 2
Immediate Management Steps
- The European Society of Cardiology recommends immediate coronary angiography for patients with ongoing myocardial ischemia despite morphine administration, to prevent life-threatening ventricular arrhythmias and limit myocardial necrosis 1, 2
- Aspirin should be administered to the patient if not already given, as recommended by the European Heart Journal 1, 4
- A P2Y12 inhibitor, such as ticagrelor, prasugrel, or clopidogrel, should be considered unless contraindicated or CABG is likely within 5 days, according to the European Heart Journal 1, 6
- Anticoagulation with fondaparinux, bivalirudin, UFH, or enoxaparin should be initiated, as recommended by the European Heart Journal 1, 7
Rationale for Urgent Intervention
- The combination of persistent chest pain and elevated troponin indicates ongoing myocardial damage that requires immediate intervention, as stated by the European Heart Journal 1, 2
- The persistence of chest pain despite morphine administration indicates ongoing ischemia that is not responding to medical therapy, highlighting the need for urgent coronary angiography 1, 3
Considerations for Heart Failure Component
- After coronary intervention, ACE inhibitors or ARBs should be initiated for patients with systolic dysfunction, as recommended by the European Heart Journal 1, 7
- Beta-blockers should be initiated once the patient is stabilized, according to the European Heart Journal 1, 7